<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>fluorouracil</title><link>http://www.unboundmedicine.com/medline/ebm/research/fluorouracil</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19894219/full_citation/Altered_fractionation_and_adjuvant_chemotherapy_for_head_and_neck_squamous_cell_carcinoma_</link><description>Mendenhall WM, Riggs CE, Vaysberg M, et al. <br/><span class="title">Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Head &amp; neck">Head Neck 2009 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19894219/abstract/Altered_fractionation_and_adjuvant_chemotherapy_for_head_and_neck_squamous_cell_carcinoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19894219/full_citation/Altered_fractionation_and_adjuvant_chemotherapy_for_head_and_neck_squamous_cell_carcinoma_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19894219/Altered_fractionation_and_adjuvant_chemotherapy_for_head_and_neck_squamous_cell_carcinoma_">Find Related Articles</a> </description></item><item><title>Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890695/full_citation/Efficacy_of_sequential_methotrexate_and_5_fluorouracil__MTX/5FU__in_improving_oral_intake_in_patients_with_advanced_gastric_cancer_with_severe_peritoneal_dissemination_</link><description>Imazawa M, Kojima T, Boku N, et al. <br/><span class="title">Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination. [Journal Article]</span><br/><span class="source" title="Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association">Gastric Cancer 2009; 12(3):153-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890695/abstract/Efficacy_of_sequential_methotrexate_and_5_fluorouracil__MTX/5FU__in_improving_oral_intake_in_patients_with_advanced_gastric_cancer_with_severe_peritoneal_dissemination_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890695/full_citation/Efficacy_of_sequential_methotrexate_and_5_fluorouracil__MTX/5FU__in_improving_oral_intake_in_patients_with_advanced_gastric_cancer_with_severe_peritoneal_dissemination_">Full Citation</a></description></item><item><title>Docetaxel: its role in current and future treatments for advanced gastric cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890692/full_citation/Docetaxel:_its_role_in_current_and_future_treatments_for_advanced_gastric_cancer_</link><description>Nishiyama M, Wada S <br/><span class="title">Docetaxel: its role in current and future treatments for advanced gastric cancer. [Journal Article]</span><br/><span class="source" title="Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association">Gastric Cancer 2009; 12(3):132-41.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890692/abstract/Docetaxel:_its_role_in_current_and_future_treatments_for_advanced_gastric_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890692/full_citation/Docetaxel:_its_role_in_current_and_future_treatments_for_advanced_gastric_cancer_">Full Citation</a></description></item><item><title>Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid - pilot study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889001/full_citation/Topical_treatment_of_actinic_keratoses_with_low_dose_5_fluorouracil_in_combination_with_salicylic_acid___pilot_study_</link><description>Schlaak M, Simon JC <br/><span class="title">Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid - pilot study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG">J Dtsch Dermatol Ges 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889001/abstract/Topical_treatment_of_actinic_keratoses_with_low_dose_5_fluorouracil_in_combination_with_salicylic_acid___pilot_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889001/full_citation/Topical_treatment_of_actinic_keratoses_with_low_dose_5_fluorouracil_in_combination_with_salicylic_acid___pilot_study_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19889001/Topical_treatment_of_actinic_keratoses_with_low_dose_5_fluorouracil_in_combination_with_salicylic_acid___pilot_study_">Find Related Articles</a> </description></item><item><title>Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in taiwan.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19888794/full_citation/Information_technology_facilitates_cost_effectiveness_analysis_in_developing_countries:_an_observational_study_of_breast_cancer_chemotherapy_in_taiwan_</link><description>Shih YC, Pan IW, Tsai YW <br/><span class="title">Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in taiwan. [Journal Article]</span><br/><span class="source" title="PharmacoEconomics">Pharmacoeconomics 2009; 27(11):947-61.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19888794/abstract/Information_technology_facilitates_cost_effectiveness_analysis_in_developing_countries:_an_observational_study_of_breast_cancer_chemotherapy_in_taiwan_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19888794/full_citation/Information_technology_facilitates_cost_effectiveness_analysis_in_developing_countries:_an_observational_study_of_breast_cancer_chemotherapy_in_taiwan_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19888794/Information_technology_facilitates_cost_effectiveness_analysis_in_developing_countries:_an_observational_study_of_breast_cancer_chemotherapy_in_taiwan_">Find Related Articles</a> </description></item><item><title>Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19887466/full_citation/Incidence_and_evolution_of_oxaliplatin_induced_peripheral_sensory_neuropathy_in_diabetic_patients_with_colorectal_cancer:_a_pooled_analysis_of_three_phase_III_studies_</link><description>Ramanathan RK, Rothenberg ML, de Gramont A, et al. <br/><span class="title">Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19887466/abstract/Incidence_and_evolution_of_oxaliplatin_induced_peripheral_sensory_neuropathy_in_diabetic_patients_with_colorectal_cancer:_a_pooled_analysis_of_three_phase_III_studies_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19887466/full_citation/Incidence_and_evolution_of_oxaliplatin_induced_peripheral_sensory_neuropathy_in_diabetic_patients_with_colorectal_cancer:_a_pooled_analysis_of_three_phase_III_studies_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19887466">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19887466/Incidence_and_evolution_of_oxaliplatin_induced_peripheral_sensory_neuropathy_in_diabetic_patients_with_colorectal_cancer:_a_pooled_analysis_of_three_phase_III_studies_">Find Related Articles</a> </description></item><item><title>Continuous 5-fluorouracil infusion plus long acting Octreotide in advanced well differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19886987/full_citation/Continuous_5_fluorouracil_infusion_plus_long_acting_Octreotide_in_advanced_well_differentiated_neuroendocrine_carcinomas__A_phase_II_trial_of_the_Piemonte_Oncology_Network_</link><description>Brizzi MP, Berruti A, Ferrero A, et al. <br/><span class="title">Continuous 5-fluorouracil infusion plus long acting Octreotide in advanced well differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network. [JOURNAL ARTICLE]</span><br/><span class="source" title="BMC cancer">BMC Cancer 2009 Nov 3; 9(1):388.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19886987/abstract/Continuous_5_fluorouracil_infusion_plus_long_acting_Octreotide_in_advanced_well_differentiated_neuroendocrine_carcinomas__A_phase_II_trial_of_the_Piemonte_Oncology_Network_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19886987/full_citation/Continuous_5_fluorouracil_infusion_plus_long_acting_Octreotide_in_advanced_well_differentiated_neuroendocrine_carcinomas__A_phase_II_trial_of_the_Piemonte_Oncology_Network_">Full Citation</a></description></item><item><title>[Evaporation of selected cytotoxic drugs and permeation of protective gloves--research into the occupational risks of health care personnel handling hazardous cytotoxic drugs (CYTO project)]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19886359/full_citation/[Evaporation_of_selected_cytotoxic_drugs_and_permeation_of_protective_gloves__research_into_the_occupational_risks_of_health_care_personnel_handling_hazardous_cytotoxic_drugs__CYTO_project_]</link><description>Dolezalová L, Odráska P, Gorná L, et al. <br/><span class="title">[Evaporation of selected cytotoxic drugs and permeation of protective gloves--research into the occupational risks of health care personnel handling hazardous cytotoxic drugs (CYTO project)] [English Abstract, Journal Article]</span><br/><span class="source" title="Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti">Klin Onkol 2009; 22(5):218-22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19886359/abstract/[Evaporation_of_selected_cytotoxic_drugs_and_permeation_of_protective_gloves__research_into_the_occupational_risks_of_health_care_personnel_handling_hazardous_cytotoxic_drugs__CYTO_project_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19886359/full_citation/[Evaporation_of_selected_cytotoxic_drugs_and_permeation_of_protective_gloves__research_into_the_occupational_risks_of_health_care_personnel_handling_hazardous_cytotoxic_drugs__CYTO_project_]">Full Citation</a></description></item><item><title>Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19885749/full_citation/Neoadjuvant_chemotherapy_with_a_combination_of_docetaxel_cisplatin_fluorouracil_and_leucovorin_in_nonresectable_advanced_gastric_cancer:_a_short_communication_</link><description>Ma Y, Qin H, Zheng Q, et al. <br/><span class="title">Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication. [JOURNAL ARTICLE]</span><br/><span class="source" title="Medical oncology (Northwood, London, England)">Med Oncol 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19885749/abstract/Neoadjuvant_chemotherapy_with_a_combination_of_docetaxel_cisplatin_fluorouracil_and_leucovorin_in_nonresectable_advanced_gastric_cancer:_a_short_communication_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19885749/full_citation/Neoadjuvant_chemotherapy_with_a_combination_of_docetaxel_cisplatin_fluorouracil_and_leucovorin_in_nonresectable_advanced_gastric_cancer:_a_short_communication_">Full Citation</a></description></item><item><title>p53 Mutation Status Predicts Pathological Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19885698/full_citation/p53_Mutation_Status_Predicts_Pathological_Response_to_Chemoradiotherapy_in_Locally_Advanced_Esophageal_Cancer_</link><description>Makino T, Yamasaki M, Miyata H, et al. <br/><span class="title">p53 Mutation Status Predicts Pathological Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of surgical oncology">Ann Surg Oncol 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19885698/abstract/p53_Mutation_Status_Predicts_Pathological_Response_to_Chemoradiotherapy_in_Locally_Advanced_Esophageal_Cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19885698/full_citation/p53_Mutation_Status_Predicts_Pathological_Response_to_Chemoradiotherapy_in_Locally_Advanced_Esophageal_Cancer_">Full Citation</a> | <a href="http://dx.doi.org/10.1245/s10434-009-0786-9">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19885698/p53_Mutation_Status_Predicts_Pathological_Response_to_Chemoradiotherapy_in_Locally_Advanced_Esophageal_Cancer_">Find Related Articles</a> </description></item></channel></rss>